Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal health.
Alexomycin (PNU-82, 127) is a thiopeptide antimicrobial complex intended for veterinary practice that belongs to a series of cyclic peptides produced by Streptomyces arginensis. MICs against selected routine and fastidious clinical isolates of animal and human origin were determined by broth microdilution or agar dilution reference methods. Alexomycin was active against Gram-positive pathogens such as oxacillin-susceptible and -resistant Staphylococcus aureus and coagulase-negative staphylococci (260 strains; MIC90, 0.5 microgram/mL), as well as Enterococcus species (95 strains; MIC90, 0.25 to 0.5 microgram/mL), and generally inactive against Gram-negative aerobes. Alexomycin had more potent activity against Streptococcus bovis (MIC90, 0.12 microgram/mL), S. agalactiae (MIC90, 0.12 microgram/mL), Corynebacterium species (MIC90, 0.06-0.12 microgram/mL), and Listeria monocytogenes (MIC90, 0.5 microgram/mL). Alexomycin activity was limited against Bacillus species (MIC90, 1 microgram/mL), Neisseria meningiditis (MIC90, 2 micrograms/mL), Haemophilus influenzae (MIC90, 8 micrograms/mL), Moraxella catarrhalis (MIC90, 16 micrograms/mL), and Campylobacter jejuni (MIC90, 32 micrograms/mL). This thiopeptide complex was also found to be stable at low concentrations (0.015-32 micrograms/mL) in Mueller-Hinton broth for up to 24 h, possesses static antimicrobial activity and did not produce resistant mutants after multiple passages at subinhibitory drug concentrations. Alexomycin seems to have potential for use as a feed additive to increase feed efficiency and promote growth in poultry and swine as well as other applications against Gram-positive pathogens.